Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Adjuvant Chemotherapy 1

Interventions

pembrolizumab 27Pemetrexed 15Cisplatin 15Carboplatin 15Paclitaxel 14Nivolumab 10Cyclophosphamide 10Docetaxel 9atezolizumab 7Injections 7Melphalan 6tislelizumab 5olaparib 5Leucovorin 5Irinotecan 5Gemcitabine 5Filgrastim 5Bevacizumab 5durvalumab 4aldesleukin 4Oxaliplatin 4Granulocyte Colony-Stimulating Factor 4Fluorouracil 4Etoposide 4tocilizumab 3spartalizumab 3liposomal doxorubicin 3ixabepilone 3fludarabine 3epacadostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tissue Plasminogen Activator × Other solid neoplasm × Clear all
NCT02492477 2018-08-21

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Krankenhaus Barmherzige Schwestern Linz

Phase 1 Terminated
4 enrolled
Other solid neoplasm

Adjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡